Search for: "Whitehead Institute for Biomedical Research"
Results 1 - 6 of 6
Sorted by Relevance | Sort by
Date
5 Jul 3:13 am
... dispute among Max Planck GmbH and Alnylam Pharmaceuticals Inc. on one side and MIT, the Whitehead Institute for Biomedical Research in Cambridge, and the University of
Massachusetts, on the other side. Syre is talking about a case in Suffolk ... further research with other scientists, all from Max Planck, that
led to new discoveries known as Tuschl II. Whitehead was responsible for securing Tuschl I patents that would be shared by the group, according
to the suit. But patents for those discoveries ...
23 Nov 9:59 pm
... eighteen briefs filed in support of Defendant-Appellant-Respondent Eli Lilly & Co. and/or affirmance, six briefs filed in support of neither party, and no amicus briefs filed in
support of Plaintiffs-Appellees-Petitioners Ariad Pharmaceuticals, Inc., Massachusetts Institute of Technology, the Whitehead Institute for Biomedical Research, and the Presidents and Fellows of Harvard College ("Ariad")....
8 Jul 7:04 am
... v Dudas (Patent Docs) US: Max-Planck-Gesellschaft and others files suit against Whitehead Institute for Biomedical Research and others alleging breach of contract
and negligence for misappropriation of inventions and inappropriate patent ... -O) (EDTexweblog.com) (PatLit) (Inventive Step) (Patent Docs) (EDTexweblog.com) Humira (Adalimumab) - US:
University of Iowa Research Foundation sues Abbott for patent infringement over manufacture of Humira (Technology Transfer Tactics)
(GenericsWeb) Levitra ( ...
7 Dec, 2007 7:54 pm
... and outs of "reprogramming skin cells" to combat sickle cell anemia. Researchers at the Whitehead Institute of Biomedical Research in Massachussetts are conducting intense
research to discover a safe way to turn skin cells into stem cells. Partly, ... DNA changes elsewhere in the body, which can lead to dangerous
complications like cancer. This is because, at the moment, researchers are using retroviruses to insert therapeutic genes into skin cells to create what they call "induced
pluripotent stem ...
10 Jul, 2007 9:51 pm
By Donald Zuhn -- On Monday, ARIAD Pharmaceuticals, Inc. announced that the U.S. District Court for the District of Massachusetts had ruled in its favor in a patent infringement suit
ARIAD filed against Eli Lilly and Co. ARIAD and co-plaintiffs Massachusetts Institute of Technology, The Whitehead Institute for Biomedical Research,...
10 Nov 9:59 pm
... patent case awaiting oral argument: the Federal Circuit's en banc rehearing of Ariad Pharmaceuticals, Inc. v. Eli Lilly & Co., which is scheduled for December 7th. Last month,
Plaintiffs-Appellees Ariad Pharmaceuticals, Massachusetts Institute of Technology, the Whitehead
Institute for Biomedical Research, and the Presidents and
Fellows of Harvard College ("Ariad") filed their principal brief for rehearing en banc. In response to the ...
Search on: Blawgs.FM | BlawgSearch Google
Co-op | Blawg.com | Bloglines | Feedster | Google Blog Search | Technorati | Google | MSN | Yahoo!